Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-intestinal Stromal Tumors (GIST)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT01689376
What this trial is testing

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

Who this might be right for
Gastrointestinal Stromal Tumors
Bayer
Not applicableStudy completedNCT02662478
What this trial is testing

Laparoscopic Resection of Large Gastric Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Medical Park Gaziantep Hospital 23
Not applicableLooking for participantsNCT05938309
What this trial is testing

A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Fujian Medical University 194
Large-scale testing (Phase 3)Looking for participantsNCT05208047
What this trial is testing

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Who this might be right for
Advanced Gastrointestinal Stromal TumorsMetastatic Cancer
Cogent Biosciences, Inc. 482
Testing effectiveness (Phase 2)Study completedNCT03944304
What this trial is testing

Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 40
Early research (Phase 1)Ended earlyNCT03114319
What this trial is testing

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLCEsophageal Squamous Cell Cancer (SCC)+4 more
Novartis Pharmaceuticals 227
Not applicableStudy completedNCT06628739
What this trial is testing

Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes

Who this might be right for
Gastrointestinal Stromal Tumor, Malignant
First Affiliated Hospital, Sun Yat-Sen University 168
Testing effectiveness (Phase 2)Study completedNCT02880020
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Gastrointestinal Stromal Tumor
Jonsson Comprehensive Cancer Center 36
Not applicableStudy completedNCT06619275
What this trial is testing

Ripretinib (QINLOCK®) According to Current SmPC

Who this might be right for
GIST - Gastrointestinal Stromal Tumor
iOMEDICO AG 10
Testing effectiveness (Phase 2)Ended earlyNCT01316263
What this trial is testing

Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Eli Lilly and Company 21
Not applicableStudy completedNCT02171286
What this trial is testing

The Oncopanel Pilot (TOP) Study

Who this might be right for
Colorectal Cancer MetastaticAdvanced Non-Small Cell Lung CarcinomaAdvanced Melanoma+2 more
British Columbia Cancer Agency 432
Testing effectiveness (Phase 2)Study completedNCT01863745
What this trial is testing

Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 15
Post-approval studies (Phase 4)Study completedNCT00171977
What this trial is testing

Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 64
Testing effectiveness (Phase 2)WithdrawnNCT05080621
What this trial is testing

Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Deciphera Pharmaceuticals, LLC
Testing effectiveness (Phase 2)Study completedNCT00112463
What this trial is testing

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+17 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT01046487
What this trial is testing

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

Who this might be right for
Cancer
Centre Oscar Lambret 26
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableUnknownNCT05697107
What this trial is testing

Ripretinib in Chinese Patients With Advanced GIST: a Real World Study

Who this might be right for
Gastrointestinal Stromal Tumors
Peking University 308
Not applicableApproved For MarketingNCT03862885
What this trial is testing

Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST

Who this might be right for
GIST
Blueprint Medicines Corporation
Testing effectiveness (Phase 2)Study completedNCT00570635
What this trial is testing

XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib

Who this might be right for
Gastrointestinal Stromal TumorsGastrointestinal Neoplasms
Exelixis 16
Next Page